Thursday, October 29, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients

NCT07728318 · NA · NOT YET RECRUITING · Sponsor: Akhtar Saeed Medical and Dental College · Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity,

PR
By Priya Raman · Science Reporter
Oct 29 08:00 ETSource: ClinicalTrials.gov

From the source

Efficacy, Safety, and Treatment Satisfaction of Once-Weekly Tirzepatide in Obese Type 2 Diabetic Patients

NCT07728318 · NA · NOT YET RECRUITING · Sponsor: Akhtar Saeed Medical and Dental College · Conditions: Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight.

Read at clinicaltrials.gov
PeptiPrescribed peptides from $99/moSee all →